MilliporeSigma Opens China’s First BioReliance End-to-End Biodevelopment Center in Shanghai Read more
Provention Bio Announces Licensing Agreements with Janssen for Two Clinical-Stage Immunology Assets Read more
NUS scientists combine antimalarial drug with light sensitive molecules for promising treatment of cancer Read more
Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases Read more